NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss. Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating. |
Biden’s new Title IX rules protect LGBTQ+ students, but transgender sports rule still on holdHurricanes overcome yellow cards to beat Fijian Drua 38UN envoy urges unified government to lead Libya to electionsHouse leaders toil to advance Ukraine and Israel aid. But threats to oust speaker growALISON BOSHOFF: Robert Downey Jr's got his OscarStaff and shoppers return to 'somber' Sydney shopping mall 6 days after mass stabbingsSouth Korea slows plan to hike medical school admissions as doctors' strike drags onUK's Princess of Wales says she is under cancer treatmentSoldiers who lost limbs in Gaza fighting are finding healing on Israel's amputee soccer teamOld mill where nursery rhyme Humpty Dumpty is said to have originated could be yours for £650,000